ECMB home page Information about ECMB Details about ECMB facilities ECMB news ECMB contact information Frequently Asked Questions  
 
 
   
Frequently asked questions

What is the European Centre for Marine Biotechnology?

The European Centre for Marine Biotechnology aims to be the business incubator of choice for new and emerging marine biotechnology companies within the UK. By establishing a growing cluster  of activity and international networks it strives to be the premier site for innovative growth and development within this emerging sector.  It is physically represented by its own purpose built wing, which is owned by the Scottish Association for Marine Science (SAMS) as an integral part of the new £12 million laboratory complex.

What can the European Centre for Marine Biotechnology provide for my business?

The European Centre for Marine Biotechnology offers fully fitted laboratory space along with modular office units to accommodate a wide variety of business needs.  Shared services such as meeting rooms, canteen and library facilities along with access to a diverse range of analytical equipment enable growing companies to obtain the results they need without significant outlay. The European Centre for Marine Biotechnology also provides a supportive and enterprising business environment in which 'start-up' and established companies can flourish. The companies involved can gain energy from the synergies of the site by taking advantage of the proximity to established marine science research, a talented resource pool and the associated support services of an international marine laboratory.  The centre benefits from significant enterprise company support, and potential clients are encouraged to open dialogues with Argyll and Islands Enterprise as part of the decision making process.

What is the benefit of my company locating to the European Centre for Marine Biotechnology?

Located on the desirable west coast of Scotland, the European Centre for Marine Biotechnology offers the opportunity to explore a diverse range of marine environments (ranging from shallow coastal environments to the deep Atlantic waters to the west).  It combines a very high standard of living with the convenience of commutable journeys to the central belt, London and further afield. The co-location with the other residents allows the establishment of beneficial synergies between the occupants making each more effective and competitive.  The close connections between our residents enable all involved to contribute towards achieving a critical mass that provides significant growth opportunities over the medium to longer term.

How can I become a resident within European Centre for Marine Biotechnology?

All you have do is send an enquiry e-mail. The European Centre for Marine Biotechnology business manager will then be able to discuss your needs and provide information regarding the units and facilities available. Should these be of interest to you, you will be welcome to come and tour the premises and agree any specialist fit-out you may require prior to concluding a lease agreement.

What lies ahead for the European Centre for Marine Biotechnology?

  • ECMB seeks to be the UK’s leading interface between applied and commercial marine biotechnology, through research excellence, the quality of infrastructure, and access to the investment market place.

  • ECMB aims to be at the centre of a network of facilities; with individuals, groups and companies moving freely between centres across the globe, enhancing collaboration and facilitating market penetration.

  • ECMB will be a significant contributor to “Smart, Successful Scotland”, and become a hub for the Blue Biotech initiatives in Scotland and Europe.

  • ECMB will become a focus for investment in related marine science park initiatives leading to the growth and development of the economy of rural, maritime Scotland.

  • ECMB will collaborate enthusiastically with networks (e.g. Faraday Partnerships), initiatives (the Marine Foresight Panel’s Marine Biotechnology Group), and European opportunities (Blue Bionet and SCANBALT).